Search

01/10/2023 GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations.
Xie F, Shemilt I, Vale L, Ruiz F, Drummond MF, Lord J, Herrmann KH, Rojas MX, Zhang Y, Canelo-Aybar C, Alonso-Coello P, Shamliyan T, Schünemann HJ. GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations.. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2023; 162DOI:10.1016/j.jclinepi.2023.08.001. PMID:37597696. IF:7.300(Q1/1D).
08/09/2023 Effects of low-level laser therapy in adults with rheumatoid arthritis: A systematic review and meta-analysis of controlled trials.
Lourinho I, Sousa T, Jardim R, Pinto AC, Iosimuta N. Effects of low-level laser therapy in adults with rheumatoid arthritis: A systematic review and meta-analysis of controlled trials.. PLoS One. 2023; 18(9)DOI:10.1371/journal.pone.0291345. PMID:37683021. IF:2.900(Q1/3D).
01/09/2023 [Translated article] Overview of systematic reviews of risk factors for prosthetic joint infection.
Sabater-Martos M, Martínez-Pastor JC, Morales A, Ferrer M, Antequera A, Roqué M. [Translated article] Overview of systematic reviews of risk factors for prosthetic joint infection.. Revista Espanola De Cirugia Ortopedica Y Traumatologia. 2023; 67(5)DOI:10.1016/j.recot.2023.06.014. PMID:37364724. IF:(Q/D).
03/08/2023 Basal procalcitonin, C-reactive protein, interleukin-6, and presepsin for prediction of mortality in critically ill septic patients: a systematic review and meta-analysis.
Molano-Franco D, Arevalo-Rodriguez I, Muriel A, Del Campo-Albendea L, Fernández-García S, Alvarez-Méndez A, Simancas-Racines D, Viteri A, Sanchez G, Fernandez-Felix B, Lopez-Alcalde J, Solà I, Osorio D, Khan KS, Nuvials X, Ferrer R, Zamora J. Basal procalcitonin, C-reactive protein, interleukin-6, and presepsin for prediction of mortality in critically ill septic patients: a systematic review and meta-analysis.. Diagnostic And Prognostic Research. 2023; 7(1)DOI:10.1186/s41512-023-00152-2. PMID:37537680. IF:(Q/D).